Answers are grounded in this paper and cite their sources.
The aim of follow-up after treatment for colorectal cancer (CRC) is twofold: For the individual patients, the aim is to detect and treat recurrence and sequelae. However, for the healthcare professional, an equally important aim is to follow the general standard of care (morbidity, early and late mortality, sequelae, etc.); to understand the consequences of changing practice i.e. robotic surgery, TaTME, new drugs, etc.; and to identify problems or fields that should be addressed in post-graduate training and trials.
No takes yet. Share an insight, caveat, or question.
Laurberg et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: